(Q35866920)

English

Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected].

scientific article published on 28 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected]. (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neoplastic stem cells

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

9

object named as

Gerardo Botti

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Margherita Cerrone

object named as

Margherita Cerrone

5

0 references

object named as

Laura Marra

6

0 references

Francesca Collina

object named as

Francesca Collina

2

0 references

Giuseppina Liguori

object named as

Giuseppina Liguori

7

0 references

object named as

Monica Cantile

3

0 references

Maurizio Di Bonito

1

object named as

Maurizio Di Bonito

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Rosalba Camerlingo

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Giuseppe Pirozzi

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

28 March 2012

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Journal of breast cancer

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

15-23

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Phenotypic heterogeneity of breast cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Cancer stem cells - A therapeutic target?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

New promising drug targets in cancer- and metastasis-initiating cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Targeting CD133 antigen in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

CD133 as a marker for cancer stem cells: progresses and concerns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Cancer stem cells in solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

BRCA1 gene expression in breast cancer: A correlative study between real-time RT-PCR and immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Self-renewal and solid tumor stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

11 July 2018

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

24 September 2018

Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

24 September 2018

AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318170

24 September 2018

Tubulolobular carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/22493624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22493624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4048/JBC.2012.15.1.15

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35866920&oldid=1867913576"